Journal Article |
| Stempak LM, Iv CEM, Navalkele B, Leasure JE, How the Pathologist Can Help the Surgeon Collect Better Specimens for Microbiology Culture. Archives of pathology & laboratory medicine, 2020 Jan;144(1):29-33 | 2020 |
| Chandramohan S, Navalkele B, Mushtaq A, Krishna A, Kacir J, Chopra T, Impact of a Multidisciplinary Infection Prevention Initiative on Central Line and Urinary Catheter Utilization in a Long-term Acute Care Hospital. Open forum infectious diseases, 2018 Jul;5(7):ofy156 | 2018 |
| Mushtaq A, Navalkele B, Kaur M, Krishna A, Saleem A, Rana N, Gera S, Chandramohan S, Surapaneni M, Chopra T, Comparison of complications in midlines versus central venous catheters: Are midlines safer than central venous lines? American journal of infection control, 2018 Jul;46(7):788-792 | 2018 |
| Navalkele BD, Henig O, Fairfax M, Flanagan E, Upfal M, Russell J, Dhar S, Kaye K, Chopra T, First case of vaccine-strain varicella infection as manifestation of HIV in healthcare worker: a case report and review of the literature. The Journal of hospital infection, 2017 Dec;97(4):384-388 | 2017 |
| Navalkele BD, Revankar S, Chandrasekar P, Candida auris: a worrisome, globally emerging pathogen. Expert review of anti-infective therapy, 2017 Sep;15(9):819-827 | 2017 |
| Navalkele B, Pogue JM, Karino S, Nishan B, Salim M, Solanki S, Pervaiz A, Tashtoush N, Shaikh H, Koppula S, Koons J, Hussain T, Perry W, Evans R, Martin ET, Mynatt RP, Murray KP, Rybak MJ, Kaye KS, Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017 Jan 15;64(2):116-123 | 2017 |
| Navalkele BD, Lerner SA, Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI. Open forum infectious diseases, 2016 Apr;3(2):ofw094 | 2016 |
| Karino S, Kaye KS, Navalkele B, Nishan B, Salim M, Solanki S, Pervaiz A, Tashtoush N, Shaikh H, Koppula S, Martin ET, Mynatt RP, Murray KP, Rybak MJ, Pogue JM, Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship. Antimicrobial agents and chemotherapy, 2016 Jun;60(6):3743-50 | 2016 |
| Gallagher JC, Reilly JP, Navalkele B, Downham G, Haynes K, Trivedi M, Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infection. Antimicrobial agents and chemotherapy, 2015 Nov;59(11):7007-10 | 2015 |
| Navalkele BD, Chopra T, Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection. Biologics : targets & therapy, 2018;12:11-21 | |
Book Chapter |
Navalkele BD Antibiotic Stewardship related to Clostridium difficile Infection in Long-Term Care Facilities Clostridium difficile Infection in Long-Term Care Facilities: A Clinician's Guide 1st Edition
Springer International Publication AG, Switzerland, November 2019 | 2019 |
Chopra T, Navalkele BD Clostridium difficile Infection in the Hospital: Infection Prevention Considerations Clinical Decision Support: Infection Control 2nd Edition
Clinical Advisor, January 18, 2019 | 2016 |
Navalkele BD, Chandrasekar P Febrile Neutropenia Manual of Clinical Oncology, 8th Edition
Wolters Kluwer Health; 8 edition, Philadelphia, 2017 | 2016 |
Electronic Publications |
| Navalkele BD, Levine M, Chandrasekar P Zika Virus: Current Perspectives | 2018 |
Comment |
| Pogue JM, Navalkele B, Kaye KS, Reply to Manian. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017 Jul 1;65(1):178-179 | 2017 |